HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	53,060	52,725	16,769	30,978	31,254	37,157
Short-Term Investments	10,622	16,212	11,298	12,350	24,690	17,858
Trading Asset Securities	232.68	10,629	50,793	88,661	84,017	103,019
Cash & Short-Term Investments	63,914	79,566	78,860	131,989	139,961	158,034
Cash Growth	-60.28%	0.90%	-40.25%	-5.70%	-11.44%	-10.08%
Accounts Receivable	19,577	18,120	11,464	13,072	11,648	17,599
Other Receivables	1,079	2,057	2,371	2,116	1,123	369.92
Receivables	23,068	20,188	14,646	16,202	14,157	19,349
Inventory	7,069	6,103	5,267	10,867	1,769	2,082
Prepaid Expenses	-	468.69	448.74	208.4	281.34	395.85
Other Current Assets	3,143	1,382	238.85	1,509	654.91	1,468
Total Current Assets	97,195	107,709	99,460	160,776	156,822	181,329
Property, Plant & Equipment	94,443	81,206	72,918	92,089	22,081	22,935
Long-Term Investments	208,025	254,694	146,038	44,749	24,346	38,850
Goodwill	-	-	1,772	21,925	-	1,896
Other Intangible Assets	58,903	44,780	54,029	69,506	62,809	75,440
Long-Term Accounts Receivable	-	-	-	341.17	363.96	571.04
Other Long-Term Assets	48,258	50,500	49,158	22,264	4,262	6,060
Total Assets	506,950	539,017	423,500	411,790	270,800	327,197
Accounts Payable	8,045	6,985	5,160	9,384	10,278	5,548
Accrued Expenses	-	2,029	2,240	697.15	717.82	584.35
Short-Term Debt	32,152	28,153	106,761	7,920	-	-
Current Portion of Long-Term Debt	15,483	12,276	7,060	387.2	-	-
Current Portion of Leases	522.43	632.14	922.33	2,145	668	377.78
Current Income Taxes Payable	28.03	52.6	7,555	132.13	-	19.36
Current Unearned Revenue	-	2.91	31.49	38.42	24.01	631.24
Other Current Liabilities	4,489	3,417	5,727	6,081	1,848	10,705
Total Current Liabilities	60,720	53,547	135,457	26,785	13,536	17,865
Long-Term Debt	96,921	82,529	51,410	136,189	3,500	10,734
Long-Term Leases	247.91	193.33	424.01	832.41	452.62	279.57
Long-Term Deferred Tax Liabilities	3,425	2,310	3,345	10,033	5,758	9,667
Other Long-Term Liabilities	3,933	1,045	1,036	1,201	224.73	250.38
Total Liabilities	165,880	140,192	192,288	175,724	24,188	39,453
Common Stock	61,421	61,416	51,407	48,831	48,223	24,009
Additional Paid-In Capital	320,019	319,343	168,141	222,910	240,895	294,133
Retained Earnings	-40,766	16,373	10,431	-40,963	-46,832	-60,188
Treasury Stock	-679.97	-679.97	-679.97	-	-	-
Comprehensive Income & Other	695.03	1,889	1,499	3,947	3,904	29,227
Total Common Equity	340,690	398,340	230,797	234,725	246,189	287,181
Minority Interest	380.49	484.91	416.21	1,342	422.87	563.11
Shareholders' Equity	341,071	398,825	231,213	236,067	246,612	287,744
Total Liabilities & Equity	506,950	539,017	423,500	411,790	270,800	327,197
Total Debt	145,327	123,783	166,578	147,473	4,621	11,391
Net Cash (Debt)	-81,413	-44,217	-87,718	-15,484	135,340	146,642
Net Cash Growth	-	-	-	-	-7.71%	-10.46%
Net Cash Per Share	-695.05	-392.35	-861.84	-153.36	1362.33	1481.19
Filing Date Shares Outstanding	121.83	121.81	101.8	96.71	100.44	49.5
Total Common Shares Outstanding	121.83	121.81	101.8	101.71	100.44	99.01
Working Capital	36,475	54,162	-35,997	133,991	143,286	163,464
Book Value Per Share	2796.54	3270.06	2267.23	2307.67	2451.22	2900.59
Tangible Book Value	281,788	353,561	174,996	143,294	183,380	209,845
Tangible Book Value Per Share	2313.04	2902.45	1719.07	1408.78	1825.85	2119.48
Land	-	21,569	21,471	29,580	9,065	9,622
Buildings	-	23,221	23,221	19,950	4,547	5,511
Machinery	-	40,056	39,219	30,949	12,906	12,541
Construction In Progress	-	33,101	8,472	18,390	1,324	392.54

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.